Physician profile
Bruce J Pistorius
NPI 1851399265
$677.53
in general payments reported to CMS, 2019-2025
14 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $15.66 · 2022: $123 · 2023: $110 · 2024: $131 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $137.98 | 2024-2025 | Qelbree |
| Glaxosmithkline, LLC. | $111.64 | 2019-2025 | Bexsero |
| Corium, LLC | $82.68 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $66.01 | 2022-2023 | Kristalose |
| Ironshore Pharmaceuticals INC. | $63.86 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $47.11 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Collegium Pharmaceutical, INC. | $43.74 | 2025 | Jornay Pm |
| Pfizer INC. | $36.52 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $19.51 | 2023 | Flumist Quadrivalent |
| Tris Pharma INC | $15.17 | 2019 | |
| Neos Therapeutics, LP | $14.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.87 | 2025 | |
| Shire North American Group INC | $13.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Pistorius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.